Use of medications to treat inflammatory bowel diseases before and during pregnancy in Switzerland between 2012 and 2019: an observational study using the claims-based MAMA cohort

Inflammatory Bowel Disease

Tonsillectomy and the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study Using Real-World US Data

Inflamm Bowel Dis

Guo JY, Wu MC, Wang YH, Lin CC, Wei JC

doi: 10.1093/ibd/izaf306

COMMENTED

Inflammatory Bowel DiseaseFurther Publications

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

★ 3 Recommended and commented by Prof. Dr Stephan Vavricka, Faculty Member

Am J Gastroenterol

Vavricka SR, Zeitz J, Madanchi M, Ruiz PA, Biedermann L, Morsy Y, Yilmaz B, Scharl M, Scharl S, Gassmann M, Lutz TA, Kunz A, Bron D, Misselwitz B, MacPherson AJ, Rogler G, Greuter T

doi: 10.14309/ajg.0000000000003888

RECOMMENDED

Inflammatory Bowel Disease

Prediction of inflammatory bowel disease based on early life risk factors in a population-based cohort

★ 1 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

Clin Gastroenterol Hepatol

Agrawal M, Hansen AV, Julsgaard M, Colombel JF, Jess T

doi: 10.1016/j.cgh.2026.01.034

Gastrointestinal CancerInflammatory Bowel Disease

Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study

Inflamm Bowel Dis

Huang YJ, Lin JA, Chen WM, Shia BC, Wu SY

doi: 10.1093/ibd/izaf304

Inflammatory Bowel Disease

Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort

Inflamm Bowel Dis

Ricciuto A, Turinsky AL, Griffiths AM, Mack DR, Wine E, Benchimol EI, El-Matary W, Huynh HQ, Carman N, deBruyn JC, Otley AR, Church PC, Jacobson K, Low S, Broer E, Lawrence S, Sherlock M, Deslandres C, Walters TD

doi: 10.1093/ibd/izaf329

Inflammatory Bowel Disease

Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study

Inflamm Bowel Dis

Boute EH, Gianolio L, Mahmmod S, Pochesci S, Armstrong K, Henderson P, Wilson DC, de Ridder L, Russell RK, Escher JC

doi: 10.1093/ibd/izaf335

Inflammatory Bowel Disease

Long-term disease course of Crohn's disease in a prospective European population-based inception cohort - an Epi-IBD cohort study

Clin Gastroenterol Hepatol

Wewer MD, Lophaven S, Lakatos PL, Gonczi L, Salupere R, Linda Kievit HA, Nielsen KR, Midjord J, Domislovic V, Krznarić Ž, Pedersen N, Kjeldsen J, Halfvarson J, Sebastian S, Goldis A, Arebi N, Oksanen P, Neumann A, Andersen V, Katsanos KH, Koukoudis A, Turcan S, Ellul P, Kupcinskas J, Kiudelis G, Fumery M, Kaimakliotis IP, D'Inca R, Lombardini S, Hernandez V, Fernandez A, Langholz E, Munkholm P, Burisch J, Epi-IBD-group.

doi: 10.1016/j.cgh.2025.10.022

Inflammatory Bowel Disease

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)

Inflamm Bowel Dis

Lin SH, Kuo CJ, Chuang CH, Chang CW, Chung CS, Chou JW, Huang TY, Yen HH, Tsai TJ, Lin CP, Chang CH, Tai CM, Tai WC, Yao CC, Chen CC, Pan YB, Le PH

doi: 10.1093/ibd/izag150

RECOMMENDED

Inflammatory Bowel Disease

Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease

★ 2 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

J Crohns Colitis

Dignass A, Narula N, Pratap K, Danese S, Dotan I, Iacucci M, Jairath V, Loftus EV Jr, Magro F, Mantzaris G, Peyrin-Biroulet L, Rubin DT, Sands BE, Turner D, Reinisch W, International Organization for the Study of IBD

doi: 10.1093/ecco-jcc/jjag007

Related content

Tonsillectomy and the Risk of Inflammatory Bowel Disease: A Retrospective Cohort Study Using Real-World US Data

A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study

Prediction of inflammatory bowel disease based on early life risk factors in a population-based cohort

Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study

Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort

Persistence and safety of subcutaneous infliximab up to 1 year after switching from intravenous infliximab in pediatric inflammatory bowel disease: a multicenter real-world cohort study

Long-term disease course of Crohn's disease in a prospective European population-based inception cohort - an Epi-IBD cohort study

Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study)

Position Paper: IOlBD Evidence-based Consensus on the Use of Artificial Intelligence for Assessment of Endoscopic and Histologic Endpoints in Clinical Trials of Inflammatory Bowel Disease